 This statistic depicts a pharmaceutical company ranking based on R&D for developing countries in 2018, according to the Access to Medicine Index 2018. In that year, the leading company concerning research and development for these markets was GlaxoSmithKline with an indicator score of four points. The Access to Medicine Index is an independent initiative that ranks the worldâ€™s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine. 